Gynecologic Cancer

Top Story

Drinking coffee reduces risk for death, negative health outcomes

November 22, 2017

Consuming coffee lowered the risk for death and a broad spectrum of health outcomes, according to a report recently published in BMJ.

“It is important to systematically assess the totality of higher level evidence of the effects of coffee consumption on all health outcomes,” Robin Poole, MB, ChB, MSc, of the academic unit of primary care and population sciences, University of Southampton, United Kingdom, and colleagues wrote. “This approach can help contextualize the magnitude of the association across health outcomes and importantly assess the existing research for any harm that could be associated with increased consumption.”

In the Journals Plus

Prevalence of secondary cancers underscores need for trial inclusion

November 22, 2017
A quarter of older adults newly diagnosed with cancer from 2009 to 2013 had a prior cancer history, according to an observational study published in JAMA Oncology. …
Meeting News

Telemedicine offers access to state-of-the-art cancer care in rural areas

November 22, 2017
NEW YORK — Every patient with cancer does not live in a major metropolitan area with direct access to specialized care, but there are ways to provide individuals…
FDA News

Seven oncology agents receive priority review

HemOnc Today, November 25, 2017
The FDA has granted priority review to seven oncology agents under investigation for the treatment of patients with solid tumors. These include:
More Headlines »
CME ABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent…
More »
Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »